Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing.  “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading ->
The Kenyan government has taken the fight against childhood obesity to the classroom through a revised school curriculum that focuses on health and healthy lifestyle behaviours. The initiative involves including science-based food and nutrition material in the academic content and introducing physical literacy from Grade One. Addressing a recent Word Obesity Federation (WOF) virtual event […] Continue reading ->
Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed.  But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading ->
As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines.  Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading ->
Though the Americas is the only World Health Organization (WHO) region that is reporting a slight decline in new COVID-19 cases this week, countries in Central and South America, Canada and Mexico are still experiencing rising rates of infection.  Over 1.1 million new COVID-19 cases were reported in the Americas over the last week, officials […] Continue reading ->
After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading ->